Koiji Sasaki (Koji Sasaki)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 189

Top Venues

American journal of hematology

Cancer

Leukemia

Blood cancer journal

The University of Texas MD Anderson Cancer Center

Tokyo Medical and Dental University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Texas MD Anderson Cancer Center

United States

Assistant Professor :: Department of Leukemia

Education History

Tokyo Medical and Dental University

Japan

PHD :: Department of Hematology, Graduate School of Medical Sciences

Publications

Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Hiroki Akiyama, Hagop Kantarjian, Elias Jabbour, Ghayas Issa, Fadi G Haddad, Nicholas J Short, Shimin Hu, Jo Ishizawa, Michael Andreeff, Koiji Sasaki
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. International journal of hematology 120 (2) (2024)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia. American journal of hematology 99 (6) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia. American journal of hematology 99 (6) (2024)
Branko Cuglievan, Hagop M Kantarjian, Jeffrey E Rubnitz, Todd M Cooper, C Michel Zwaan, Jessica A Pollard, Courtney D D DiNardo, Tapan Mahendra Kadia, Erin M Guest, Nicholas James Short, David C McCall, Naval G Daver, Cesar Nunez, Fadi G Haddad, Miriam B Garcia, Kapil N Bhalla, Abhishek Maiti, Samanta Catueno, Warren C Fiskus, Bing Z Carter, Amber Gibson, Michael Roth, Sajad Khazal, Priti Tewari, Hussein A Abbas, Wallace Bourgeois, Michael Andreeff, Neerav N Shukla, Danh D Truong, Jeremy Connors, Joseph A Ludwig, Janine Stutterheim, Elisabeth Salzer, Kristian L Juul-Dam, Koiji Sasaki, Kris M Mahadeo, Sarah K Tasian, Gautam Borthakur, Samantha Dickson, Nitin Jain, Elias J Jabbour, Soheil Meshinchi, Guillermo Garcia Manero, Farhad Ravandi, Eytan M Stein, E Anders Kolb, Ghayas C Issa
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. Leukemia (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Fady Gh Haddad, Koiji Sasaki, Jayastu Senapati, Lianchun Xiao, Grace S Hwang, Tareq Abuasab, Sangeetha Venugopal, Daniel Rivera, Alexandre Bazinet, Rodrick Babakhanlou, Kunhwa Kim, Faustine Ong, Sai Desikan, Naveen Pemmaraju, Sanam Loghavi, Gautam Borthakur, Courtney DiNardo, Hussein A Abbas, Nicholas James Short, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis. JCO oncology practice (2024)
Hiroki Akiyama, Hagop Kantarjian, Elias Jabbour, Ghayas Issa, Fadi G Haddad, Nicholas J Short, Shimin Hu, Jo Ishizawa, Michael Andreeff, Koiji Sasaki
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. International journal of hematology 120 (2) (2024)
Hiroki Akiyama, Hagop Kantarjian, Elias Jabbour, Ghayas Issa, Fadi G Haddad, Nicholas J Short, Shimin Hu, Jo Ishizawa, Michael Andreeff, Koiji Sasaki
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. International journal of hematology (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology (2024)
Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick K Reville, Nicholas James Short, Naval G Daver, Gautam Borthakur, Alex Bataller, Elias J Jabbour, Courtney D D DiNardo, Fady Gh Haddad, Koiji Sasaki, Uday R Popat, Betül Oran, Amin M Alousi, Sanam Loghavi, Elizabeth Shpall, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology 99 (7) (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia 38 (5) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Fady Gh Haddad, Koiji Sasaki, Lewis Fady Nasr, Nicholas James Short, Tapan Mahendra Kadia, Sara Dellasala, Jorge Cortes, Franck Emmanuel Nicolini, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Cancer 130 (19) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 38 (5) (2024)
Georgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, Kelly Sharon Chien, Andres E Quesada, Emmanuel Almanza-Huante, Danielle Hammond, Koiji Sasaki, Courtney D D DiNardo, Tapan Mahendra Kadia, Naval G Daver, Gautam Borthakur, Ghayas C Issa, Nicholas James Short, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia Manero, Guillermo Montalban Bravo
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage. Cancer (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology 99 (7) (2024)
Elias J Jabbour, Fady Gh Haddad, Koiji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Fady Nasr, Lucia Masarova, Naval G Daver, Naveen Pemmaraju, Nicholas James Short, Jeffrey Skinner, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop M Kantarjian
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer (2024)
Warren Fiskus, Jessica Piel, Michael P Collins, Murphy Hentemann, Branko Cuglievan, Christopher P Mill, Christine Birdwell, Kaberi Das, John A Davis, Hanxi Hou, Antrix Jain, Anna Malovannaya, Tapan M Kadia, Naval G Daver, Koiji Sasaki, Koichi Takahashi, Danielle Hammond, Patrick K Reville, Jian Wang, Sanam Loghavi, Rwik Sen, Xinjia Ruan, Xiaoping Su, Lauren B Flores, Courtney D D DiNardo, Kapil N Bhalla
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor. Blood (2024)
Warren Fiskus, Jessica Piel, Michael P Collins, Murphy Hentemann, Branko Cuglievan, Christopher P Mill, Christine Birdwell, Kaberi Das, John A Davis, Hanxi Hou, Antrix Jain, Anna Malovannaya, Tapan M Kadia, Naval G Daver, Koiji Sasaki, Koichi Takahashi, Danielle Hammond, Patrick K Reville, Jian Wang, Sanam Loghavi, Rwik Sen, Xinjia Ruan, Xiaoping Su, Lauren B Flores, Courtney D D DiNardo, Kapil N Bhalla
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor. Blood (2024)
Bofei Wang, Patrick K Reville, Mhd Yousuf Yassouf, Fatima Zahra Jelloul, Christopher Ly, Poonam N Desai, Zhe Wang, Pamella Borges, Ivo Veletic, Enes Dasdemir, Jared K Burks, Guillin Tang, Shengnan Guo, Araceli Isabella Garza, Cedric Nasnas, Nicole R Vaughn, Natalia Baran, Qing Deng, Jairo Matthews, Preethi H Gunaratne, Dinler A Antunes, Suhendan Ekmekcioglu, Koiji Sasaki, Miriam B Garcia, Branko Cuglievan, Dapeng Hao, Naval G Daver, Michael R Green, Marina Y Konopleva, P Andrew Futreal, Sean M Post, Hussein A Abbas
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nature communications 15 (1) (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Bofei Wang, Patrick K Reville, Mhd Yousuf Yassouf, Fatima Zahra Jelloul, Christopher Ly, Poonam N Desai, Zhe Wang, Pamella Borges, Ivo Veletic, Enes Dasdemir, Jared K Burks, Guillin Tang, Shengnan Guo, Araceli Isabella Garza, Cedric Nasnas, Nicole R Vaughn, Natalia Baran, Qing Deng, Jairo Matthews, Preethi H Gunaratne, Dinler A Antunes, Suhendan Ekmekcioglu, Koiji Sasaki, Miriam B Garcia, Branko Cuglievan, Dapeng Hao, Naval G Daver, Michael R Green, Marina Y Konopleva, P Andrew Futreal, Sean M Post, Hussein A Abbas
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nature communications 15 (1) (2024)
Fady Gh Haddad, Koiji Sasaki, Lewis Fady Nasr, Nicholas James Short, Tapan Mahendra Kadia, Sara Dellasala, Jorge Cortes, Franck Emmanuel Nicolini, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Cancer (2024)
Bofei Wang, Patrick K Reville, Mhd Yousuf Yassouf, Fatima Zahra Jelloul, Christopher Ly, Poonam N Desai, Zhe Wang, Pamella Borges, Ivo Veletic, Enes Dasdemir, Jared K Burks, Guillin Tang, Shengnan Guo, Araceli Isabella Garza, Cedric Nasnas, Nicole R Vaughn, Natalia Baran, Qing Deng, Jairo Matthews, Preethi H Gunaratne, Dinler A Antunes, Suhendan Ekmekcioglu, Koiji Sasaki, Miriam B Garcia, Branko Cuglievan, Dapeng Hao, Naval G Daver, Michael R Green, Marina Y Konopleva, P Andrew Futreal, Sean M Post, Hussein A Abbas
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nature communications 15 (1) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Bofei Wang, Patrick K Reville, Mhd Yousuf Yassouf, Fatima Zahra Jelloul, Christopher Ly, Poonam N Desai, Zhe Wang, Pamella Borges, Ivo Veletic, Enes Dasdemir, Jared K Burks, Guillin Tang, Shengnan Guo, Araceli Isabella Garza, Cedric Nasnas, Nicole R Vaughn, Natalia Baran, Qing Deng, Jairo Matthews, Preethi H Gunaratne, Dinler A Antunes, Suhendan Ekmekcioglu, Koiji Sasaki, Miriam B Garcia, Branko Cuglievan, Dapeng Hao, Naval G Daver, Michael R Green, Marina Y Konopleva, P Andrew Futreal, Sean M Post, Hussein A Abbas
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nature communications 15 (1) (2024)
Hagop M Kantarjian, Gautam Borthakur, Naval G Daver, Courtney D D DiNardo, Ghayas C Issa, Elias J Jabbour, Tapan Mahendra Kadia, Koiji Sasaki, Nicholas James Short, Musa Ylimaz, Farhad Ravandi
Current status and research directions in acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Warren C Fiskus, Jessica Piel, Michael P Collins, Murphy Hentemann, Branko Cuglievan, Christopher P Mill, Christine E Birdwell, Kaberi Das, John A Davis, Hanxi Hou, Antrix Jain, Anna Malovannaya, Tapan M Kadia, Naval G Daver, Koiji Sasaki, Koichi Takahashi, Danielle Hammond, Patrick K Reville, Jian Wang, Sanam Loghavi, Rwik Sen, Xinjia Ruan, Xiaoping Su, Lauren B Flores, Courtney D D DiNardo, Kapil N Bhalla
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood 143 (20) (2024)
Wei-Ying Jen, Koiji Sasaki, Sanam Loghavi, Sa A Wang, Wei Qiao, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Naval G Daver, Courtney D D DiNardo
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British journal of haematology 204 (6) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 38 (5) (2024)
Elias J Jabbour, Fady Gh Haddad, Koiji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Fady Nasr, Lucia Masarova, Naval G Daver, Naveen Pemmaraju, Nicholas James Short, Jeffrey Skinner, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop M Kantarjian
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer 130 (15) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick K Reville, Nicholas James Short, Naval G Daver, Gautam Borthakur, Alex Bataller, Elias J Jabbour, Courtney D D DiNardo, Fady Gh Haddad, Koiji Sasaki, Uday R Popat, Betül Oran, Amin M Alousi, Sanam Loghavi, Elizabeth Shpall, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer 130 (19) (2024)
Wei-Ying Jen, Koiji Sasaki, Sanam Loghavi, Sa A Wang, Wei Qiao, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Naval G Daver, Courtney D D DiNardo
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British journal of haematology (2024)
Warren C Fiskus, Jessica Piel, Michael P Collins, Murphy Hentemann, Branko Cuglievan, Christopher P Mill, Christine E Birdwell, Kaberi Das, John A Davis, Hanxi Hou, Antrix Jain, Anna Malovannaya, Tapan M Kadia, Naval G Daver, Koiji Sasaki, Koichi Takahashi, Danielle Hammond, Patrick K Reville, Jian Wang, Sanam Loghavi, Rwik Sen, Xinjia Ruan, Xiaoping Su, Lauren B Flores, Courtney D D DiNardo, Kapil N Bhalla
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood 143 (20) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances (2024)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Koiji Sasaki, Fady Gh Haddad, Nicholas James Short, Nitin Jain, Ghayas Issa, Elias J Jabbour, Hagop M Kantarjian
Outcome of Philadelphia chromosome-positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy-The Surveillance, Epidemiology, and End Results database, 2000-2019. Cancer (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Alexandre Bazinet, Tapan M Kadia, Nicholas James Short, Gautam Borthakur, Sa A Wang, Wei Wang, Sanam Loghavi, Jeffrey L Jorgensen, Keyur Pravinchandra Patel, Courtney D D DiNardo, Naval G Daver, Yesid Alvarado, Fadi G Haddad, Sherry R Pierce, Graciela Nogueras Gonzalez, Abhishek Maiti, Koiji Sasaki, Musa Ylimaz, Phillip A Thompson, William G Wierda, Guillermo Garcia-Manero, Michael Andreeff, Elias J Jabbour, Marina Y Konopleva, Xuelin Huang, Hagop M Kantarjian, Farhad Ravandi
Undetectable Measurable Residual Disease is Associated with Improved Outcomes in AML Irrespective of Treatment Intensity. Blood advances (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic Myeloid Leukemia Without Major Molecular Response After 2 Years of Treatment with Tyrosine Kinase Inhibitor. American journal of hematology (2023)
Hagop M Kantarjian, Mary Alma Welch, Koiji Sasaki
Early mortality after chemotherapy as a quality indicator-the leukemia perspective. Blood cancer journal 13 (1) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-line BCR::ABL1 Tyrosine Kinase Inhibitors. American journal of hematology (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Fadi G Haddad, Hagop M Kantarjian, Aram Bidikian, Elias J Jabbour, Nicholas James Short, Jing Ning, Lianchun Xiao, Naveen Pemmaraju, Courtney D D DiNardo, Tapan Mahendra Kadia, Kayleigh R Marx, Guillermo Garcia Manero, Farhad Ravandi, Koiji Sasaki, Ghayas C Issa
Association between bariatric surgery and outcomes in chronic myeloid leukemia. Cancer (2023)
Gaku Oshikawa, Koiji Sasaki
Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities. Cancers 15 (8) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, Naval G Daver, Koiji Sasaki, Helen T Chifotides, Lingsha Zhou, Hagop M Kantarjian, Zeev Estrov, Srdan Verstovsek
The role of therapy in the outcome of patients with myelofibrosis. Cancer (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology 98 (4) (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma 64 (3) (2023)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Ziyi Li, Danielle Hammond, Kelly Sharon Chien, Juan Jose Rodriguez-Sevilla, Koiji Sasaki, Elias Jabbour, Courtney DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop Kantarjian, Guillermo Garcia Manero
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia. British journal of haematology (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Gaku Oshikawa, Koiji Sasaki
Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities. Cancers 15 (8) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Emmanuel Almanza-Huante, Alex Bataller, Samuel Urrutia, Georgina Gener-Ricos, Robert Edward Briski, Rashmi Kanagal-Shamana, Karen H Lu, Shannon N Westin, Timothy A Yap, Koichi Takahashi, Farhad Ravandi, Yesid Alvarado, Tapan Kadia, Koiji Sasaki, Hagop M Kantarjian, Guillermo Garcia Manero
Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours. British journal of haematology (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D D DiNardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Kunhwa Kim, Faustine Ong, Koiji Sasaki
Current Understanding of DDX41 Mutations in Myeloid Neoplasms. Cancers 15 (2) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Kunhwa Kim, Faustine Ong, Koiji Sasaki
Current Understanding of DDX41 Mutations in Myeloid Neoplasms. Cancers 15 (2) (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D D DiNardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Fady Gh Haddad, Koiji Sasaki, Aram Bidikian, Ghayas C Issa, Tapan Mahendra Kadia, Nitin Jain, Yesid Alvarado, Nicholas James Short, Naveen Pemmaraju, Sanam Loghavi, Keyur P Patel, Rashmi Kanagal-Shamana, Musa Ylimaz, Lucia Masarova, Elias J Jabbour, Hagop M Kantarjian
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era. American journal of hematology (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Elias J Jabbour, Fadi G Haddad, Nicholas James Short, Jayastu Senapati, Nitin Jain, Koiji Sasaki, Jeffrey L Jorgensen, Sa A Wang, Yesid Alvarado, Xuemei Wang, Courtney D D DiNardo, Lucia Masarova, Tapan M Kadia, Rebecca Garris, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Inotuzumab Ozogamicin for Measurable Residual Disease in Acute Lymphoblastic Leukemia in Remission. Blood (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D D DiNardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Samuel Urrutia, Ziyi Li, Emmanuel Almanza, Alex Bataller, Rashmi Kanagal-Shamana, Jayastu Senapati, Koiji Sasaki, Kelly Sharon Chien, Guillermo Montalban-Bravo, Courtney D D DiNardo, Gautam Borthakur, Carlos Bueso-Ramos, Sherry Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations. Leukemia (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology 98 (4) (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology (2023)
Alexandre Bazinet, Hagop M Kantarjian, Naszrin Arani, Uday Popat, Alex Bataller, Koiji Sasaki, Courtney D D DiNardo, Naval G Daver, Musa Ylimaz, Hussein A Abbas, Nicholas James Short, Ghayas C Issa, Elias J Jabbour, Sherry A Pierce, Julianne Chen, Ricky Garcia, Marina Konopleva, Guillermo Garcia Manero, Amin Alousi, Elizabeth J Shpall, Richard E Champlin, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation. American journal of hematology (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D D DiNardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Urrutia Argueta, Kelly Sharon Chien, Ziyi Li, Alex Bataller, Emmanuel Almanza, Koiji Sasaki, Guillermo Montalban Bravo, Nicholas James Short, Elias J Jabbour, Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Yesid Alvarado, Naval G Daver, Rashmi Kanagal-Shamana, Carlos Bueso-Ramos, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure. American journal of hematology (2023)

Koiji Sasaki.css-eqlu8i{font-size:small;padding-left:4px;} (Koji Sasaki)

Publication Activity (10 Years)

Top Topics

Top Venues

Koiji Sasaki (Koji Sasaki)